Outbreak of septicaemic cases caused by Acinetobacter ursingii in a neonatal intensive care unit

International Journal of Medical Microbiology : IJMM
Krisztina MáderSándor Túri

Abstract

Neonatal infections may be caused by various microorganisms, but as far as we are aware, Acinetobacter ursingii has not yet been reported in connection with nosocomial infections of premature infants. During 2 months, 3 premature babies were treated with nosocomial infection caused by A. ursingii at the same ward, and on the basis of molecular typing results the same strain was responsible for all of these cases. Traditional biochemical methods and automatic identification systems failed to identify this bacterium on the species level, and only 16S rDNA sequencing gave acceptable species identifications. The isolated strains proved to be susceptible to all of the tested antimicrobials, including ampicillin/sulbactam, doxycyclin, netilmicin, ciprofloxacin, piperacillin/tazobactam, ceftazidime, imipenem, meropenem, trimethoprim/sulfametoxazole, gentamicin, tobramycin, amikacin, and levofloxacin according to the CLSI standard. In spite of the environmental screening, the source of the infection could not be clarified. One of 3 neonates died, the others recovered and were discharged home after several months of hospitalization.

References

May 31, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L A MermelUNKNOWN Society for Healthcare Epidemiology of America
Oct 12, 2001·International Journal of Systematic and Evolutionary Microbiology·A NemecL Dijkshoorn
Mar 8, 2003·Journal of Clinical Microbiology·Julien LoubinouxAnne Bouvet
May 3, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Maria Virginia Villegas, Alan I Hartstein
Aug 2, 2003·International Journal of Systematic and Evolutionary Microbiology·Emma L CarrRobert J Seviour
Nov 11, 2003·Journal of Microbiological Methods·G C BakerD A Cowan
Aug 6, 2008·Journal of Clinical Microbiology·Alexandr NemecLenie Dijkshoorn

❮ Previous
Next ❯

Citations

Apr 29, 2011·Journal of Clinical Microbiology·Flávia Lúcia Piffano Costa PellegrinoBeatriz Meurer Moreira
Dec 23, 2015·Emerging Infectious Diseases·Helmut J F SalzerHarald Seifert
Oct 28, 2019·BMJ Case Reports·Mariana BarrosManuel Sousa Cunha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Clinical and Diagnostic Research : JCDR
Atul KhajuriaNaveen Grover
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Philip TurnerMYSTIC Study Group (Europe)
© 2022 Meta ULC. All rights reserved